SonoScape Medical Corp. (SHE:300633)
China flag China · Delayed Price · Currency is CNY
20.80
+0.28 (1.36%)
Aug 4, 2026, 3:04 PM CST

SonoScape Medical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Revenue
2,3602,3092,0142,1201,7631,445
Revenue Growth
20.11%14.65%-5.02%20.29%22.02%24.20%
Gross Profit
1,4131,3891,2281,4001,138911.46
Operating Income
126.91111.27100.97457.68320.99216.21
Net Income
177.6197.28142.4454.44369.81247.24
Earnings Per Share
0.410.460.331.050.860.62
EPS Growth
255.48%39.39%-68.57%22.09%38.71%-

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Jan '24 Jan '23 Jan '22
Foreign
1,140970.16939.39794.46665.58
China
1,1691,0441,181968.19779.02
Total
2,3092,0142,1201,7631,445

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Cash & Investments
1,4201,6642,0091,8261,7571,415
Total Debt
275.39310.14354.7972.44218.89110.74
Net Cash (Debt)
1,1451,3541,6551,7541,5381,304
Net Cash Growth
-13.48%-18.16%-5.64%14.03%17.93%188.04%
Net Cash Per Share
2.673.163.834.053.583.27

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Operating Cash Flow
96.92-48.16306.66489.47473.26302.99
Capital Expenditures
-136.35-142.24-206.86-176.99-190.32-152.25
Free Cash Flow
-39.43-190.499.8312.48282.93150.74
Free Cash Flow Growth
---68.06%10.44%87.69%30.13%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Gross Margin
59.87%60.16%60.96%66.03%64.59%63.09%
Operating Margin
5.38%4.82%5.01%21.59%18.21%14.97%
Pretax Margin
5.95%7.11%5.97%22.35%21.67%17.60%
Profit Margin
7.53%8.54%7.07%21.43%20.98%17.11%
FCF Margin
-1.67%-8.25%4.96%14.74%16.05%10.44%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Dividend Per Share
0.1800.1800.1000.3200.1800.125
Dividend Per Share Growth
80.00%80.00%-68.75%77.78%44.00%-
Dividend Yield
0.89%0.69%0.34%0.69%0.34%0.40%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
PE Ratio
49.5957.5688.8844.8263.4451.91
Forward PE
35.4533.1625.8734.5857.5350.58
P/FCF Ratio
--126.8265.1982.9285.13
PS Ratio
3.694.926.299.6113.318.88